Chen Jia-lin, Li Shu-lan, Xu Min, Wang Hai-bin, Ge Chang-wen, Li Rong-sheng
Department of Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100730, China.
Zhonghua Nei Ke Za Zhi. 2004 Jun;43(6):423-5.
To study the clinical significance of the serum transferrin receptor (sTfR) and ferritin in distinguishing between iron deficiency anemia (IDA), anemia of chronic disease (ACD) and ACD with complicating IDA (ACD-IDA).
One hundred and thirteen subjects enrolled into the study were divided into four groups including 28 health volunteers as control, 29 patients with IDA, 27 patients with ACD (sTfR level <or= 20.0 nmol/L, ACD1 group) and 29 patients with ACD-IDA (sTfR level > 20.0 nmol/L, ACD2 group). sTfR, serum ferritin (SF), serum iron (SI), total iron-binding capacity (TIBC), transferring saturation (TS) and complete blood count were measured in all the enrolled subjects or patients. Bone marrow iron stain was examined in 10 cases of ACD1 and 16 cases of ADC2.
In IDA group, MCV (68.0 +/- 11.3) fl was the smallest; SI, TS and SF were significantly decreased but sTfR level was increased as compared with the control group (SI) (19.6 +/- 10.1) mg/L vs (81.7 +/- 30.6) mg/L, TS (5.5 +/- 2.3)% vs (27.0 +/- 12.0)%, SF (4.3 +/- 2.8) micro g/L vs (43.3 +/- 26.8) micro g/L and sTfR (67.2 +/- 40.3) nmol/L vs (15.6 +/- 4.1) nmol/L (P <or= 0.01). SI (60.7 +/- 28.7) mg/L, and TS (21.1 +/- 9.8)% were not different statistically (P > 0.05) but SF (627.3 +/- 40.3) micro g/L level was increased in ACD1 group as compared with the control group (P < 0.01). Bone marrow iron stain showed no iron deficiency in 10 cases of ACD1. In ACD2 group, SF (320.5 +/- 156.0) micro g/L level was higher than that of the control group, but lower than that of the ACD1 group (P <or= 0.01); bone marrow iron stain showed iron depletion in 14 of the 16 patients.
High sTfR level may reflect iron deficiency status of the body and is a more sensitive parameter to diagnose iron deficiency anemia. sTfR level is less influenced by chronic inflammation, and able to distinguish ACD from ACD-IDA.
研究血清转铁蛋白受体(sTfR)和铁蛋白在鉴别缺铁性贫血(IDA)、慢性病贫血(ACD)以及合并IDA的ACD(ACD-IDA)中的临床意义。
纳入本研究的113名受试者分为四组,包括28名健康志愿者作为对照组,29例IDA患者,27例ACD患者(sTfR水平≤20.0 nmol/L,ACD1组)和29例ACD-IDA患者(sTfR水平>20.0 nmol/L,ACD2组)。对所有纳入的受试者或患者测量sTfR、血清铁蛋白(SF)、血清铁(SI)、总铁结合力(TIBC)、转铁蛋白饱和度(TS)及全血细胞计数。对10例ACD1患者和16例ACD2患者进行骨髓铁染色检查。
IDA组平均红细胞体积(MCV)(68.0±11.3)fl最小;与对照组相比,SI、TS和SF显著降低,但sTfR水平升高(SI)(19.6±10.1)mg/L对(81.7±30.6)mg/L,TS(5.5±2.3)%对(27.0±12.0)%,SF(4.3±2.8)μg/L对(43.3±26.8)μg/L,sTfR(67.2±40.3)nmol/L对(15.6±4.1)nmol/L(P≤0.01)。ACD1组SI(60.7±28.7)mg/L和TS(21.1±9.8)%与对照组相比无统计学差异(P>0.05),但SF(627.3±40.3)μg/L水平高于对照组(P<0.01)。10例ACD1患者骨髓铁染色显示无缺铁。ACD2组SF(320.5±156.0)μg/L水平高于对照组,但低于ACD1组(P≤0.01);16例患者中14例骨髓铁染色显示铁耗竭。
高sTfR水平可能反映机体缺铁状态,是诊断缺铁性贫血更敏感的参数。sTfR水平受慢性炎症影响较小,能够区分ACD与ACD-IDA。